Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study

Annals of Oncology

Volumn 25, Issue 10, 2014, Pages 2025-2030

  Fallah, M ^a   Liu, X ^b   Ji, J ^b   Forsti A ^a,b   Sundquist, K ^b   Hemminki, K ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

Author keywords

autoimmune diseases; autoimmunity; hematology; non Hodgkin lymphoma; standardized incidence ratio; Sweden

Indexed keywords

AGED; AUTOIMMUNE DISEASES; COHORT ANALYSIS; COMPLICATION; FEMALE; FOLLOW UP; HUMAN; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PATHOLOGY; SWEDEN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; SWEDEN;

EID: 84921340062     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu365     Document Type: Article

References (31)

1. Hemminki, K., Liu, X., Ji, J., et al. Effect of autoimmune diseases on mortality and survival in subsequent digestive tract cancers. Ann Oncol 23 (2012), 2179–2184.
2. Hemminki, K., Liu, X., Ji, J., et al. Kaposi sarcoma and Merkel cell carcinoma after autoimmune disease. Int J Cancer 131 (2012), E326–E328.
3. Hemminki, K., Liu, X., Forsti, A., et al. Subsequent leukaemia in autoimmune disease patients. Br J Haematol 161 (2013), 677–687.
4. Liu, X., Ji, J., Forsti, A., et al. Autoimmune disease and subsequent urological cancer. J Urol 189 (2013), 2262–2268.
5. Hemminki, K., Liu, X., Ji, J., et al. Effect of autoimmune diseases on risk and survival in female cancers. Gynecol Oncol 127 (2012), 180–185.
6. Hemminki, K., Liu, X., Ji, J., et al. Effect of autoimmune diseases on risk and survival in histology-specific lung cancer. Eur Respir J 40 (2012), 1489–1495.
7. Hemminki, K., Liu, X., Forsti, A., et al. Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma. J Hematol Oncol, 5, 2012, 59.
8. Fallah, M., Liu, X., Ji, J., et al. Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype. Ann Oncol 25 (2014), 1397–1404.
9. Conde, L., Bracci, P.M., Halperin, E., Skibola, C.F., A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases. Genomics 98 (2011), 9–14.
10. Mellemkjaer, L., Pfeiffer, R.M., Engels, E.A., et al. Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum 58 (2008), 657–666.
11. Anderson, L.A., Gadalla, S., Morton, L.M., et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 125 (2009), 398–405.
12. Ekstrom Smedby, K., Vajdic, C.M., Falster, M., et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111 (2008), 4029–4038.
13. Jonsson, M.V., Theander, E., Jonsson, R., Predictors for the development of non-Hodgkin lymphoma in primary Sjogren's syndrome. Presse Med 41 (2012), e511–e516.
14. Goldin, L.R., Landgren, O., Autoimmunity and lymphomagenesis. Int J Cancer 124 (2009), 1497–1502.
15. Brown, L.M., Gridley, G., Check, D., Landgren, O., Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 111 (2008), 3388–3394.
16. Landgren, A.M., Landgren, O., Gridley, G., et al. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 117 (2011), 1163–1171.
17. Vajdic, C.M., van Leeuwen, M.T., Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 125 (2009), 1747–1754.
18. Rothwell, P.M., Price, J.F., Fowkes, F.G., et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 379 (2012), 1602–1612.
19. Rothwell, P.M., Fowkes, F.G., Belch, J.F., et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377 (2011), 31–41.
20. Engholm, G., Ferlay, J., Christensen, N., et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries. Copenhagen: Association of the Nordic Cancer Registries, 25.04.2014 Edition. 2014, Danish Cancer Society.
21. Shankland, K.R., Armitage, J.O., Hancock, B.W., Non-Hodgkin lymphoma. Lancet 380 (2012), 848–857.
22. Townsend, W., Linch, D., Hodgkin's lymphoma in adults. Lancet 380 (2012), 836–847.
23. Amur, S., Parekh, A., Mummaneni, P., Sex differences and genomics in autoimmune diseases. J Autoimmun 38 (2012), J254–J265.
24. Quintero, O.L., Amador-Patarroyo, M.J., Montoya-Ortiz, G., et al. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 38 (2012), J109–J119.
25. Hemminki, K., Li, X., Sundquist, K., Sundquist, J., Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalizations in Sweden. J Epidemiol Community Health 62 (2008), 398–401.
26. Hemminki, K., Li, X., Sundquist, K., Sundquist, J., Familial risks for asthma among twins and other siblings based on hospitalizations in Sweden. Clin Exp Allergy 37 (2007), 1320–1325.
27. LeBien, T.W., Tedder, T.F., B lymphocytes: how they develop and function. Blood 112 (2008), 1570–1580.
28. Lossius, A., Johansen, J.N., Torkildsen, O., et al. Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis-association and causation. Viruses 4 (2013), 3701–3730.
29. Meresse, B., Malamut, G., Cerf-Bensussan, N., Celiac disease: an immunological jigsaw. Immunity 36 (2012), 907–919.
30. Ngalamika, O., Zhang, Y., Yin, H., et al. Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review. J Autoimmun 39 (2012), 451–465.
31. Hansen, A., Lipsky, P.E., Dorner, T., B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol 3 (2007), 561–569.